D-0257-2024 Class III Ongoing
FDA drug recall D-0257-2024 was initiated by Amerisource Health Services LLC on Dec 26, 2023 and is designated Class III. Reason for recall: Superpotent drug: Assay results were slightly above specification at the time zero point. The recall status is ongoing. Affected quantity: 6,344 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 31, 2024
- Initiation Date
- Dec 26, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,344 cartons
Product description
Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11
Reason for recall
Superpotent drug: Assay results were slightly above specification at the time zero point.
Distribution pattern
Nationwide in the USA
Code information
Lot # 1014208, Exp Mar/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0257-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026